The Mdr1ab(−/−) mice (3 per dose rate) injected subcutaneously at dose rates of 0.11, 0.40 and 0.69 µmol/kg bw for IVM and 1.27, 1.64 and 2.56 µmol/kg bw for MOX were observed and the development of s
Biopharmaceutical research often uses a binary “fold-increase” response variable defined by the ratio of a pair of interval-censored measurements taken at baseline and end-of-study. Conventional pract
